Screener
Axsome Therapeutics AXSM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$51.31M-7.0% | -$64.54M-8.6% | -$28.56M+61.9% | -$47.23M+26.9% | -$47.97M+39.5% | ||
| $143K+19.2% | $116K-22.1% | $114K-11.6% | $120K-8.4% | $120K-14.3% | ||
| $27.15M+10.3% | $23.44M+0.6% | $22.73M+3.4% | $23.1M+6.7% | $24.61M+15.1% | ||
| -$32.95M-1.6% | -$20.7M+52.3% | -$18.65M+28.8% | $0+100% | -$32.42M-7.7% | ||
| $450K+3,362% | $121K-64.2% | $71K+137% | $58K-35.6% | $13K-75.0% | ||
| -$450K-3,362% | -$121K+64.2% | -$71K-137% | -$58K+35.6% | -$13K+75.0% | ||
| $70M— | $70M— | $70M— | $70M— | —— | ||
| $48.15M+39.4% | $2.99M-89.8% | $16.39M+15.0% | $21.27M-30.1% | $34.54M+140% | ||
| —— | -$17.83M-23.4% | —— | $22.26M— | —— | ||
| -$33.4M-3.0% | -$20.82M+52.4% | -$18.72M+28.6% | $0+100% | -$32.44M-7.5% |
FAQ
- How much cash does Axsome Therapeutics generate?
- Axsome Therapeutics (AXSM) generated -$72.3M in operating cash flow over the trailing twelve months.
- What is Axsome Therapeutics's free cash flow?
- After $700.0K of capital expenditures, Axsome Therapeutics's free cash flow was -$72.9M over the trailing twelve months, up 39.8% year over year.
- Where does Axsome Therapeutics's cash flow data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
